The Role of Monolaurin in the Treatment of Bacterial Infections
Bacterial infections are relatively common today. While the use of antibiotics has been an effective approach to the treatment of these infections for many years, modern-day healthcare systems are recognizing the increased prevalence of antibiotic resistance. One study [Ref #1] explains that the widespread resistance against antibiotic drugs is caused by the misuse and the overuse of antibiotics. Untreated bacterial infections, even in the case of antibiotic resistance, can lead to fatal complications.
Different types of bacterial infections have been identified in human patients [Ref #2]. These infections can often be classified as primary or secondary, as well as either acute or chronic. A bacterial infection can also be localized, pyogenic or generalized. Infections can affect different parts of the body, including the lungs, the throat, the gums, stomach, and other areas.
Monolaurin In The Treatment Of Infection
The human body is a host to billions of microorganisms, including bacteria. While many of these organisms are beneficial for the human body, some of them can be pathogenic, which means they cause harm. The infestation of pathogenic bacteria species in the human body can lead to the development of an infection.
This calls for the scientists to start looking at alternative options for the treatment of bacterial infections. Many natural treatments have been suggested for the use against the presence of an infection caused by bacterium species in the human body, but only a few of these substances hold clinically significant data behind their effectiveness. Monolaurin is one particular substance that has been proven effective.
Monolaurin is a naturally-derived medium chain fatty acid that can be extracted from glycerin and lauric acid [Red#3]. The substance is also a coconut fat byproduct. While this substance has become quite popular in the preservation of food, recent studies have started to take a look at the use of Monolaurin in bacterial infections.
Numerous scientific studies have been conducted and proven the effectiveness of Monolaurin in the treatment of infections caused by specific types of bacterium species.
- Straphylococcus Aureus – This bacteria can cause skin infections, pneumonia, endocarditis, sepsis, meningitis, osteomyelitis, and more. The species have also been associated with toxic shock syndrome. One study [Ref #4] found the extracts of Monolaurin from coconut oil, combined with an agent known as lactic acid, very effective in the treatment of bacterial infections caused by the Staphylococcus aureus species. The study explains that Monolaurin resulted in a loss of membranes and cytoplasm in Staphylococcus aureus bacteria cells.
- Enteroccocus – A group of bacterium species that often causes wound infections, as well as infections in soft tissue within the human body. One study [Ref #5] found the use of Monolaurin extracts to be statistically significant when the effects of this extract were tested on Staphylococcus aureus, Enterobacter spp, Enterococcus spp, E. vulneris, and Streptococcus spp. All of the tests performed in these studies were performed on samples obtained from skin infections.
- Escherichia Coli – Often referred to as E. coli, when pathogenic, these bacteria can cause infections to develop in the intestines, leading to gastrointestinal discomfort, pain and other accompanying symptoms. Studies have proven Monolaurin concentrations of 20mg/ml to be effective in reducing colony growth density in human subjects.
Infections caused by bacteria can cause life-threatening complications. Antibiotics are the conventional treatment option used to eliminate the presence of a bacterial infection, but with an increased prevalence of antibiotic resistance, the world is looking for alternative methods to help treat these infections. Monolaurin has the potential to assist with the elimination of infections caused by particular types of bacterium species.
Lean more about the bacterium Monolaurin has been researched to treat on the Research page.
- C. L. Ventola. The Antibiotic Resistance Crisis. Journal of Pharmacy and Therapeutics. April 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
- J.W. Peterson. Bacterial Pathogenesis. Medical Microbiology. 4th edition. https://www.ncbi.nlm.nih.gov/books/NBK8526/
- J. Seladi-Schulman. What Is Monolaurin? Healthline. 22 August 2017. https://www.healthline.com/health/monolaurin
- P. Tangwatcharin, P. Khopaibool. Activity of virgin coconut oil, lauric acid or monolaurin in combination with lactic acid against Staphylococcus aureus. U.S. National Library of Medicine. July 2012. https://www.ncbi.nlm.nih.gov/pubmed/23077821
- B.G. Carpo, V.M. Verallo-Rowell, J. Kabara. Novel antibacterial activity of monolaurin compared with conventional antibiotics against organisms from sin infections: an in vitro study. U.S. National Library of Medicine. October 2007. https://www.ncbi.nlm.nih.gov/pubmed/17966176
Doctor, author and fitness enthusiast, Ahmed Zayed, MD, is a surgery resident with a passion for helping people live a happy healthy life. Dr. Zayed is a contributing author for Natural Cure Labs.